Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors

Nanoscale Research Letters

Volumn 6, Issue , 2011, Pages

  Urbán, Patricia ^a,b,c   Estelrich, Joan ^b,c   Adeva, Alberto ^c   Cortés, Alfred ^c,d,e   Fernàndez Busquets, Xavier ^a,b,c  

^a INSTITUTE FOR BIOENGINEERING OF CATALONIA IBEC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Antimalarial chemotherapy; Chloroquine; Fosmidomycin; Half antibodies; Immunoliposomes; Malaria; Nanomedicine; Targeted drug delivery

Indexed keywords

BLOOD; CELL CULTURE; CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; LIPOSOMES; MEDICAL NANOTECHNOLOGY; MEDICINE; MONOCLONAL ANTIBODIES;

ANTIMALARIAL CHEMOTHERAPIES; CHLOROQUINE; FOSMIDOMYCIN; HALF-ANTIBODIES; IMMUNOLIPOSOMES; MALARIA;

TARGETED DRUG DELIVERY;

PLASMODIUM FALCIPARUM;

EID: 84856024401     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-6-620     Document Type: Article

References (33)

1. World Malaria Report 2009 [www.who.int/malaria/world_malaria_report_2009/en/]
2. Kappe SH, Vaughan AM, Boddey JA, Cowman AF: That was then but this is now: malaria research in the time of an eradication agenda. Science 2010, 328:862-866.
3. Vangapandu S, Jain M, Kaur K, Patil P, Patel SR, Jain R: Recent advances in antimalarial drug development. Med Res Rev 2007, 27:65-107.
4. Okiro EA, Al Taiar A, Reyburn H, Idro R, Berkley JA, Snow RW: Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity. Malar J 2009, 8:4.
5. Wells TN, Alonso PL, Gutteridge WE: New medicines to improve control and contribute to the eradication of malaria. Nat Rev Drug Discov 2009, 8:879-891.
6. Tuteja R: Malaria -an overview. FEBS J 2007, 274:4670-4679.
7. Griffith KS, Lewis LS, Mali S, Parise ME: Treatment of malaria in the United States: a systematic review. JAMA 2007, 297:2264-2277.
8. Enserink M: Malaria's drug miracle in danger. Science 2010, 328:844-846.
9. Na-Bangchang K, Karbwang J: Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development. Fundam Clin Pharmacol 2009, 23:387-409.
10. White NJ: Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 1997, 41:1413-1422.
11. Orive G, Hernández RM, Rodríguez Gascón A, Domínguez-Gil A, Pedraz JL: Drug delivery in biotechnology: present and future. Curr Opin Biotechnol 2003, 14:659-664.
12. Zhang Z, Cao W, Jin H, Lovell JF, Yang M, Ding L, Chen J, Corbin I, Luo Q, Zheng G: Biomimetic nanocarrier for direct cytosolic drug delivery. Angew Chem Int Ed Engl 2009, 48:9171-9175.
13. Santos-Magalhaes NS, Mosqueira VC: Nanotechnology applied to the treatment of malaria. Adv Drug Deliv Rev 2010, 62:560-575.
14. Farokhzad OC, Langer R: Impact of nanotechnology on drug delivery. ACS Nano 2009, 3:16-20.
15. Date AA, Joshi MD, Patravale VB: Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev 2007, 59:505-521.
16. Storm G, Wilms HP, Crommelin DJ: Liposomes and biotherapeutics. Biotherapy 1991, 3:25-42.
17. Maurer N, Fenske DB, Cullis PR: Developments in liposomal drug delivery systems. Expert Opin Biol Ther 2001, 1:923-947.
18. Barenholz Y: Liposome application: problems and prospects. Curr Opinion Coll Interface Sci 2001, 6:66-77.
19. Robinson AM, Creeth JE, Jones MN: The specificity and affinity of immunoliposome targeting to oral bacteria. Biochim Biophys Acta 1998, 1369:278-286.
20. Owais M, Varshney GC, Choudhury A, Chandra S, Gupta CM: Chloroquine encapsulated in malaria-infected erythrocyte-specific antibody-bearing liposomes effectively controls chloroquine-resistant Plasmodium berghei infections in mice. Antimicrob Agents Chemother 1995, 39:180-184.
21. Postma NS, Hermsen CC, Zuidema J, Eling WM: Plasmodium vinckei: optimization of desferrioxamine B delivery in the treatment of murine malaria. Exp Parasitol 1998, 89:323-330.
22. Postma NS, Crommelin DJ, Eling WM, Zuidema J: Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice. J Pharmacol Exp Ther 1999, 288:114-120.
23. Robertson RT, Baratta JL, Haynes SM, Longmuir KJ: Liposomes incorporating a Plasmodium amino acid sequence target heparan sulfate binding sites in liver. J Pharm Sci 2008, 97:3257-3273.
24. Longmuir KJ, Robertson RT, Haynes SM, Baratta JL, Waring AJ: Effective targeting of liposomes to liver and hepatocytes in vivo by incorporation of a Plasmodium amino acid sequence. Pharm Res 2006, 23:759-769.
25. Urbán P, Estelrich J, Cortés A, Fernàndez-Busquets X: A nanovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus noninfected red blood cells in vitro. J Control Release 2011, 151:202-211.
26. MacDonald RC, MacDonald RI, Menco BP, Takeshita K, Subbarao NK, Hu LR: Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. Biochim Biophys Acta 1991, 1061:297-303.
27. Martin FJ, Papahadjopoulos D: Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting. J Biol Chem 1982, 257:286-288
28. Koppenhagen FJ, Storm G, Underberg WJ: Development of a routine analysis method for liposome encapsulated recombinant interleukin-2. J Chromatogr B Biomed Sci Appl 1998, 716:285-291.
29. Cranmer SL, Magowan C, Liang J, Coppel RL, Cooke BM: An alternative to serum for cultivation of Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 1997, 91:363-365.
30. Lambros C, Vanderberg JP: Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 1979, 65:418-420.
31. Leivar P, González VM, Castel S, Trelease RN, López-Iglesias C, Arró M, Boronat A, Campos N, Ferrer A, Fernàndez-Busquets X: Subcellular localization of Arabidopsis 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Plant Physiol 2005, 137:57-69.
32. Yayon A, Ginsburg H: The transport of chloroquine across human erythrocyte membranes is mediated by a simple symmetric carrier. Biochim Biophys Acta 1982, 686:197-203.
33. Ashley CE, Carnes EC, Phillips GK, Padilla D, Durfee PN, Brown PA, Hanna TN, Liu J, Phillips B, Carter MB, Carroll NJ, Jiang X, Dunphy DR, Willman CL, Petsev DN, Evans DG, Parikh AN, Chackerian B, Wharton W, Peabody DS, Brinker CJ: The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater 2011, 10:389-397.